The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when dibucaine is combined with citalopram.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Fospropofol is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Olmesartan is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when lidocaine is combined with amoxapine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Efonidipine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when lorazepam is combined with MELPERONE.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Tolcapone.


The risk or severity of adverse effects can be increased when midazolam is combined with Paliperidone.


The risk or severity of adverse effects can be increased when diazepam is combined with Flupentixol.


The risk or severity of adverse effects can be increased when tiapride is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when proparacaine is combined with butamben.


The risk or severity of adverse effects can be increased when apraclonidine is combined with hydralazine.


The risk or severity of adverse effects can be increased when Tadalafil is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Almotriptan is combined with Lurasidone.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with eperisone.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with amcinonide.


The risk or severity of adverse effects can be increased when nicergoline is combined with Regorafenib.


The risk or severity of adverse effects can be increased when salicylamide is combined with flumethasone.


The risk or severity of adverse effects can be increased when morphine is combined with butorphanol.


The risk or severity of adverse effects can be increased when Alogliptin is combined with lisinopril.


The risk or severity of adverse effects can be increased when fosinopril is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when Miltefosine is combined with nimodipine.


The risk or severity of adverse effects can be increased when methysergide is combined with Nilotinib.


The risk or severity of adverse effects can be increased when fosinopril is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when meperidine is combined with metolazone.


The risk or severity of adverse effects can be increased when olanzapine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when haloprogin is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when aspirin is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when secobarbital is combined with propoxyphene.


The risk or severity of adverse effects can be increased when secobarbital is combined with dyclonine.


The risk or severity of adverse effects can be increased when thiopental is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when cocaine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Masoprocol is combined with nimesulide.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with ritonavir.


The risk or severity of adverse effects can be increased when ethopropazine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when Bortezomib is combined with penbutolol.


The risk or severity of adverse effects can be increased when terbinafine is combined with xylometazoline.


The risk or severity of adverse effects can be increased when Remoxipride is combined with trimipramine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with procaine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Toloxatone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Pirlindole.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with promethazine.


The risk or severity of adverse effects can be increased when triamcinolone is combined with fleroxacin.


The risk or severity of adverse effects can be increased when perphenazine is combined with enflurane.


The risk or severity of adverse effects can be increased when dibucaine is combined with felbamate.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when isoflurane is combined with promethazine.


The risk or severity of adverse effects can be increased when Pregabalin is combined with simvastatin.


The risk or severity of adverse effects can be increased when Perospirone is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Normethadone is combined with carisoprodol.


The risk or severity of adverse effects can be increased when naratriptan is combined with olanzapine.


The risk or severity of adverse effects can be increased when perphenazine is combined with etizolam.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with doxepin.


The risk or severity of adverse effects can be increased when amobarbital is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when isoflurane is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with nefazodone.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Etidocaine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with nicardipine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when Olmesartan is combined with minoxidil.


The risk or severity of adverse effects can be increased when bromocriptine is combined with efavirenz.


The risk or severity of adverse effects can be increased when clomipramine is combined with morphine.


The risk or severity of adverse effects can be increased when Lacidipine is combined with thalidomide.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Mometasone.


The risk or severity of adverse effects can be increased when pramipexole is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with clonazepam.


The risk or severity of adverse effects can be increased when indomethacin is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when indomethacin is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when moclobemide is combined with Flupentixol.


The risk or severity of adverse effects can be increased when haloperidol is combined with cetirizine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with ethotoin.


The risk or severity of adverse effects can be increased when Pipamperone is combined with tretinoin.


The risk or severity of adverse effects can be increased when phentolamine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when isoflurane is combined with methazolamide.


The risk or severity of adverse effects can be increased when methylergonovine is combined with topotecan.


The risk or severity of adverse effects can be increased when isoflurane is combined with Eplerenone.


The risk or severity of adverse effects can be increased when isoflurane is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when HEROIN is combined with fexofenadine.


The risk or severity of adverse effects can be increased when levorphanol is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when prilocaine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Arotinolol is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when methysergide is combined with antipyrine.


The risk or severity of adverse effects can be increased when ketamine is combined with prazepam.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when oxymorphone is combined with promethazine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with clonazepam.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Melatonin.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with procarbazine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with cocaine.


The risk or severity of adverse effects can be increased when ethosuximide is combined with scopolamine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with reserpine.


The risk or severity of adverse effects can be increased when tretinoin is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when LEVOBUNOLOL is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with tiapride.


The risk or severity of adverse effects can be increased when codeine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when carisoprodol is combined with clonidine.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with clonazepam.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with promethazine.


The risk or severity of adverse effects can be increased when Eplerenone is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Bortezomib is combined with dipyridamole.


The risk or severity of adverse effects can be increased when triflupromazine is combined with dantrolene.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when diltiazem is combined with Clevidipine.


The risk or severity of adverse effects can be increased when isoxsuprine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when ondansetron is combined with thiamylal.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when terconazole is combined with nifedipine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with ambenonium.


The risk or severity of adverse effects can be increased when butorphanol is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when phenobarbital is combined with chlormezanone.


The risk or severity of adverse effects can be increased when butorphanol is combined with Asenapine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Flibanserin.


The risk or severity of adverse effects can be increased when temazepam is combined with bromazepam.


The risk or severity of adverse effects can be increased when Clofarabine is combined with thioridazine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with paramethasone.


The risk or severity of adverse effects can be increased when lisinopril is combined with Nebivolol.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when thalidomide is combined with Milnacipran.


The risk or severity of adverse effects can be increased when isoflurane is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Droxicam.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when Normethadone is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when propranolol is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Lurasidone is combined with butalbital.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with pentazocine.


The risk or severity of adverse effects can be increased when Etidocaine is combined with maprotiline.


The risk or severity of adverse effects can be increased when tiapride is combined with methylphenidate.


The risk or severity of adverse effects can be increased when tiapride is combined with methocarbamol.


The risk or severity of adverse effects can be increased when tiapride is combined with triprolidine.


The risk or severity of adverse effects can be increased when Pipotiazine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when triamterene is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when hydromorphone is combined with amitriptyline.


The risk or severity of adverse effects can be increased when maprotiline is combined with Flibanserin.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Tolcapone.


The risk or severity of adverse effects can be increased when chlormezanone is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when pramipexole is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when butorphanol is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when reserpine is combined with nifedipine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with gabapentin.


The risk or severity of adverse effects can be increased when oxycodone is combined with gabapentin.


The risk or severity of adverse effects can be increased when lisinopril is combined with etodolac.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with DESONIDE.


The risk or severity of adverse effects can be increased when risperidone is combined with ketamine.


The risk or severity of adverse effects can be increased when oxycodone is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when etizolam is combined with baclofen.


The risk or severity of adverse effects can be increased when propofol is combined with Nebivolol.


The risk or severity of adverse effects can be increased when benztropine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Olopatadine is combined with clonazepam.


The risk or severity of adverse effects can be increased when fluocinonide is combined with tubocurarine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Carbetocin.


The risk or severity of adverse effects can be increased when Masoprocol is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when clonidine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when bromazepam is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when olanzapine is combined with thiamylal.


The risk or severity of adverse effects can be increased when benztropine is combined with Pentolinium.


The risk or severity of adverse effects can be increased when ethanol is combined with citalopram.


The risk or severity of adverse effects can be increased when tioconazole is combined with nifedipine.


The risk or severity of adverse effects can be increased when xylometazoline is combined with pravastatin.


The risk or severity of adverse effects can be increased when rapamycin is combined with quinapril.


The risk or severity of adverse effects can be increased when metolazone is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Nebivolol.


The risk or severity of adverse effects can be increased when METAXALONE is combined with venlafaxine.


The risk or severity of adverse effects can be increased when rasagiline is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when clonidine is combined with tiagabine.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Sacubitril is combined with dipyridamole.


The risk or severity of adverse effects can be increased when loxapine is combined with primidone.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when Sacubitril is combined with azelastine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when risperidone is combined with HEROIN.


The risk or severity of adverse effects can be increased when citalopram is combined with Phenelzine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with meclizine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with bromocriptine.


The risk or severity of adverse effects can be increased when clotrimazole is combined with xylometazoline.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with dexamethasone.


The risk or severity of adverse effects can be increased when oxycodone is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Tixocortol.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when procaine is combined with butalbital.


The risk or severity of adverse effects can be increased when nalbuphine is combined with pargyline.


The risk or severity of adverse effects can be increased when butamben is combined with Retigabine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with clonidine.


The risk or severity of adverse effects can be increased when sulpiride is combined with Flibanserin.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with tizanidine.


The risk or severity of adverse effects can be increased when Etomidate is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when METAXALONE is combined with ethotoin.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with meclizine.


The risk or severity of adverse effects can be increased when Pomalidomide is combined with leflunomide.


The risk or severity of adverse effects can be increased when rasagiline is combined with Lurasidone.


The risk or severity of adverse effects can be increased when trimetrexate is combined with Clevidipine.


The risk or severity of adverse effects can be increased when fluoxetine is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when fluoxetine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when formestane is combined with ambenonium.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with ACENOCOUMAROL.


The risk or severity of adverse effects can be increased when Desloratadine is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when amobarbital is combined with Agomelatine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with clidinium.


The risk or severity of adverse effects can be increased when butenafine is combined with nitrendipine.


The risk or severity of adverse effects can be increased when propofol is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when propofol is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when amphotericin b is combined with terazosin.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when nalbuphine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when ketorolac is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when flurazepam is combined with tetracaine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with zopiclone.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with topiramate.


The risk or severity of adverse effects can be increased when penbutolol is combined with Riociguat.


The risk or severity of adverse effects can be increased when mecamylamine is combined with methyldopa.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when mecamylamine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when fenbufen is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when meperidine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when butabarbital is combined with diazepam.


The risk or severity of adverse effects can be increased when temazepam is combined with mesoridazine.


The risk or severity of adverse effects can be increased when temazepam is combined with maprotiline.


The risk or severity of adverse effects can be increased when labetalol is combined with quinapril.


The risk or severity of adverse effects can be increased when labetalol is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when labetalol is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Torasemide is combined with Nebivolol.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when nabumetone is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when THYMOL is combined with barnidipine.


The risk or severity of adverse effects can be increased when zopiclone is combined with butamben.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with IDARUBICIN.


The risk or severity of adverse effects can be increased when carvedilol is combined with Varenicline.


The risk or severity of adverse effects can be increased when Butethal is combined with Iloperidone.


The risk or severity of adverse effects can be increased when carvedilol is combined with hydralazine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when bromazepam is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Almotriptan.


The risk or severity of adverse effects can be increased when irbesartan is combined with penbutolol.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with kanamycin.


The risk or severity of adverse effects can be increased when quetiapine is combined with nitrazepam.


The risk or severity of adverse effects can be increased when rescinnamine is combined with tolmetin.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Asenapine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with promethazine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with clonazepam.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Phenelzine is combined with isoproterenol.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Ticagrelor.


The risk or severity of adverse effects can be increased when Phenelzine is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when zopiclone is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Phenelzine is combined with promethazine.


The risk or severity of adverse effects can be increased when Melatonin is combined with zotepine.


The risk or severity of adverse effects can be increased when midazolam is combined with Flibanserin.


The risk or severity of adverse effects can be increased when amobarbital is combined with Melatonin.


The risk or severity of adverse effects can be increased when amobarbital is combined with clonazepam.


The risk or severity of adverse effects can be increased when amobarbital is combined with promethazine.


The risk or severity of adverse effects can be increased when estazolam is combined with maprotiline.


The risk or severity of adverse effects can be increased when promazine is combined with midazolam.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when prilocaine is combined with clomipramine.


The risk or severity of adverse effects can be increased when carisoprodol is combined with tiagabine.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Difenoxin.


The risk or severity of adverse effects can be increased when carisoprodol is combined with zonisamide.


The risk or severity of adverse effects can be increased when indomethacin is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when pergolide is combined with GLYCEROL PHENYLBUTYRATE.


The risk or severity of adverse effects can be increased when Toloxatone is combined with mirtazapine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with MELPERONE.


The risk or severity of adverse effects can be increased when hydromorphone is combined with zotepine.


The risk or severity of adverse effects can be increased when diclofenac is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when Rufinamide is combined with scopolamine.


The risk or severity of adverse effects can be increased when lidocaine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when diclofenac is combined with Salsalate.


The risk or severity of adverse effects can be increased when valsartan is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when Pipamperone is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when chloroxine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with dexamethasone.


The risk or severity of adverse effects can be increased when Torasemide is combined with methyldopa.


The risk or severity of adverse effects can be increased when propranolol is combined with indapamide.


The risk or severity of adverse effects can be increased when bupivacaine is combined with prazosin.


The risk or severity of adverse effects can be increased when bupivacaine is combined with loratadine.


The risk or severity of adverse effects can be increased when meperidine is combined with methazolamide.


The risk or severity of adverse effects can be increased when meperidine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when meperidine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with topiramate.


The risk or severity of adverse effects can be increased when levorphanol is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when diclofenac is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when amifostine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when pimozide is combined with nitrazepam.


The risk or severity of adverse effects can be increased when doxazosin is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with EDOXABAN.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with ethotoin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when indomethacin is combined with sulindac.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with loratadine.


The risk or severity of adverse effects can be increased when clorazepate is combined with ethosuximide.


The risk or severity of adverse effects can be increased when morphine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with hydralazine.


The risk or severity of adverse effects can be increased when morphine is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when secobarbital is combined with buspirone.


The risk or severity of adverse effects can be increased when clorazepate is combined with thiopental.


The risk or severity of adverse effects can be increased when morniflumate is combined with Olopatadine.


The risk or severity of adverse effects can be increased when valsartan is combined with benazepril.


The risk or severity of adverse effects can be increased when suprofen is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with apraclonidine.


The risk or severity of adverse effects can be increased when benzocaine is combined with primidone.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with brotizolam.


The risk or severity of adverse effects can be increased when etizolam is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when phentolamine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when phentolamine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when epoprostenol is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Agomelatine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when doxepin is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when methylene blue is combined with isoetharine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Zucapsaicin.


The risk or severity of adverse effects can be increased when Halazepam is combined with citalopram.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when pentazocine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when pentazocine is combined with amoxapine.


The risk or severity of adverse effects can be increased when benazepril is combined with Naftifine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Nelarabine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with equilin.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with dibucaine.


The risk or severity of adverse effects can be increased when butamben is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when trimipramine is combined with terbutaline.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with hydromorphone.


The risk or severity of adverse effects can be increased when butabarbital is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Droxicam is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when Eprosartan is combined with aspirin.


The risk or severity of adverse effects can be increased when amisulpride is combined with flunarizine.


The risk or severity of adverse effects can be increased when butabarbital is combined with clonazepam.


The risk or severity of adverse effects can be increased when butabarbital is combined with promethazine.


The risk or severity of adverse effects can be increased when butabarbital is combined with amisulpride.


The risk or severity of adverse effects can be increased when Rosuvastatin is combined with mecamylamine.


The risk or severity of adverse effects can be increased when fexofenadine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Repaglinide.


The risk or severity of adverse effects can be increased when ramipril is combined with epirizole.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with etodolac.


The risk or severity of adverse effects can be increased when ketoprofen is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when sulpiride is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when midazolam is combined with tetracaine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with MELPERONE.


The risk or severity of adverse effects can be increased when perphenazine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with cinoxacin.


The risk or severity of adverse effects can be increased when nicergoline is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with levodopa.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with buspirone.


The risk or severity of adverse effects can be increased when tretinoin is combined with enalapril.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when nicergoline is combined with acetaminophen.


The risk or severity of adverse effects can be increased when Eprosartan is combined with fosinopril.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Melatonin is combined with doxepin.


The risk or severity of adverse effects can be increased when ethanol is combined with Isotretinoin.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Difenoxin.


The risk or severity of adverse effects can be increased when doxepin is combined with levodopa.


The risk or severity of adverse effects can be increased when phenindione is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when topiramate is combined with carisoprodol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with prazosin.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with loratadine.


The risk or severity of adverse effects can be increased when Melatonin is combined with nefazodone.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Mometasone.


The risk or severity of adverse effects can be increased when felbamate is combined with sertraline.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with imipramine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with baclofen.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Mersalyl.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with doxepin.


The risk or severity of adverse effects can be increased when lithium ion is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when ketoprofen is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when tubocurarine is combined with methadone.


The risk or severity of adverse effects can be increased when lithium ion is combined with Pramocaine.


The risk or severity of adverse effects can be increased when risperidone is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when isoflurane is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when indomethacin is combined with DESONIDE.


The risk or severity of adverse effects can be increased when furosemide is combined with acetyldigitoxin.


The risk or severity of adverse effects can be increased when codeine is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when glutethimide is combined with duloxetine.


The risk or severity of adverse effects can be increased when pimozide is combined with clidinium.


The risk or severity of adverse effects can be increased when thiotepa is combined with clozapine.


The risk or severity of adverse effects can be increased when glutethimide is combined with fluoxetine.


The risk or severity of adverse effects can be increased when dyclonine is combined with levodopa.


The risk or severity of adverse effects can be increased when clorazepate is combined with perphenazine.


The risk or severity of adverse effects can be increased when dicumarol is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when lidocaine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when methysergide is combined with RUCAPARIB.


The risk or severity of adverse effects can be increased when bifonazole is combined with bepridil.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when alprazolam is combined with Ramelteon.


The risk or severity of adverse effects can be increased when ramipril is combined with isradipine.


The risk or severity of adverse effects can be increased when bifonazole is combined with Pinaverium.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Halobetasol.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when selegiline is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when ATROPINE is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when amobarbital is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when acebutolol is combined with acetylcholine.


The risk or severity of adverse effects can be increased when Trospium is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when rizatriptan is combined with olanzapine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when chlormezanone is combined with nefazodone.


The risk or severity of adverse effects can be increased when chlormezanone is combined with doxepin.


The risk or severity of adverse effects can be increased when midazolam is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when resveratrol is combined with haloperidol.


The risk or severity of adverse effects can be increased when nitrazepam is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when halcinonide is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with sertraline.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with irbesartan.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with floctafenine.


The risk or severity of adverse effects can be increased when flurazepam is combined with fludiazepam.


The risk or severity of adverse effects can be increased when quinapril is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when methylphenidate is combined with levodopa.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Propiverine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Tapentadol.


The risk or severity of adverse effects can be increased when benztropine is combined with Mirabegron.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with brotizolam.


The risk or severity of adverse effects can be increased when methocarbamol is combined with meclizine.


The risk or severity of adverse effects can be increased when Apixaban is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when Paliperidone is combined with quazepam.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with diflorasone.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Mometasone.


The risk or severity of adverse effects can be increased when medrysone is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with isradipine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Nabilone is combined with Telmisartan.


The risk or severity of adverse effects can be increased when Nabilone is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Nabilone is combined with methyldopa.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when oxaprozin is combined with paramethasone.


The risk or severity of adverse effects can be increased when diflunisal is combined with difluprednate.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when isradipine is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with dantrolene.


The risk or severity of adverse effects can be increased when diflunisal is combined with halcinonide.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with digoxin.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with sulpiride.


The risk or severity of adverse effects can be increased when enalapril is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when clozapine is combined with metolazone.


The risk or severity of adverse effects can be increased when topiramate is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when tenoxicam is combined with chloroquine.


The risk or severity of adverse effects can be increased when levorphanol is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with venlafaxine.


The risk or severity of adverse effects can be increased when trazodone is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when reserpine is combined with dantrolene.


The risk or severity of adverse effects can be increased when isradipine is combined with penbutolol.


The risk or severity of adverse effects can be increased when terbinafine is combined with nitrendipine.


The risk or severity of adverse effects can be increased when Iloperidone is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Nepafenac is combined with ketoprofen.


The risk or severity of adverse effects can be increased when reserpine is combined with lidocaine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Propacetamol.


The risk or severity of adverse effects can be increased when reserpine is combined with clemastine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with clonazepam.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with promethazine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when buspirone is combined with sulpiride.


The risk or severity of adverse effects can be increased when Sitagliptin is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with thalidomide.


The risk or severity of adverse effects can be increased when buspirone is combined with carisoprodol.


The risk or severity of adverse effects can be increased when benzocaine is combined with Perospirone.


The risk or severity of adverse effects can be increased when Salsalate is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Bretylium.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when zonisamide is combined with Iloperidone.


The risk or severity of adverse effects can be increased when triamcinolone is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when Aclidinium is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with hyoscyamine.


The risk or severity of adverse effects can be increased when cocaine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with methimazole.


The risk or severity of adverse effects can be increased when hexetidine is combined with cinnarizine.


The risk or severity of adverse effects can be increased when quinapril is combined with Bretylium.


The risk or severity of adverse effects can be increased when Articaine is combined with cetirizine.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with equilin.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with Pregabalin.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when pergolide is combined with Enasidenib.


The risk or severity of adverse effects can be increased when Calcium citrate is combined with Calcipotriol.


The risk or severity of adverse effects can be increased when methocarbamol is combined with promethazine.


The risk or severity of adverse effects can be increased when methocarbamol is combined with clonazepam.


The risk or severity of adverse effects can be increased when tenoxicam is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when dicyclomine is combined with Pentolinium.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with aspirin.


The risk or severity of adverse effects can be increased when midazolam is combined with doxepin.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with captopril.


The risk or severity of adverse effects can be increased when bromocriptine is combined with spironolactone.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with ketoprofen.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with maprotiline.


The risk or severity of adverse effects can be increased when hydromorphone is combined with estazolam.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Isavuconazonium.


The risk or severity of adverse effects can be increased when Asenapine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with mesoridazine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when alprazolam is combined with midazolam.


The risk or severity of adverse effects can be increased when loteprednol is combined with enoxacin.


The risk or severity of adverse effects can be increased when clorazepate is combined with glutethimide.


The risk or severity of adverse effects can be increased when hydromorphone is combined with dantrolene.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with cetirizine.


The risk or severity of adverse effects can be increased when barnidipine is combined with methazolamide.


The risk or severity of adverse effects can be increased when salicylic acid is combined with barnidipine.


The risk or severity of adverse effects can be increased when diazepam is combined with Tolcapone.


The risk or severity of adverse effects can be increased when felodipine is combined with penbutolol.


The risk or severity of adverse effects can be increased when Vorinostat is combined with clozapine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with nifedipine.


The risk or severity of adverse effects can be increased when perphenazine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when minoxidil is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with papaverine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with plicamycin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with nimodipine.


The risk or severity of adverse effects can be increased when isradipine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when bromocriptine is combined with sulpiride.


The risk or severity of adverse effects can be increased when bromocriptine is combined with progesterone.


The risk or severity of adverse effects can be increased when alprazolam is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when celiprolol is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when Glubionate calcium is combined with Calcium acetate.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with 4-PHENYLBUTYRIC ACID.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Sorafenib.


The risk or severity of adverse effects can be increased when azelastine is combined with difluprednate.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Melatonin.


The risk or severity of adverse effects can be increased when Clobetasone is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when isoflurane is combined with tiapride.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with cetirizine.


The risk or severity of adverse effects can be increased when alprazolam is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Apremilast.


The risk or severity of adverse effects can be increased when Olopatadine is combined with fenbufen.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when pentamidine is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when atenolol is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Phenelzine.


The risk or severity of adverse effects can be increased when Glubionate calcium is combined with Doxercalciferol.


The risk or severity of adverse effects can be increased when itraconazole is combined with cinnarizine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with dipivefrin.


The risk or severity of adverse effects can be increased when nitric oxide is combined with reserpine.


The risk or severity of adverse effects can be increased when amifostine is combined with Clofarabine.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with argatroban.


The risk or severity of adverse effects can be increased when amcinonide is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when budesonide is combined with donepezil.


The risk or severity of adverse effects can be increased when levorphanol is combined with cetirizine.


The risk or severity of adverse effects can be increased when levorphanol is combined with protriptyline.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with clonazepam.


The risk or severity of adverse effects can be increased when Tramadol is combined with etizolam.


The risk or severity of adverse effects can be increased when Melatonin is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Spirapril is combined with meperidine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with oxaprozin.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Propacetamol.


The risk or severity of adverse effects can be increased when benzoic acid is combined with xylometazoline.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when Trospium is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when docetaxel is combined with Nelarabine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Asenapine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when nadolol is combined with floctafenine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Benidipine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with flunarizine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when HEROIN is combined with acetazolamide.


The risk or severity of adverse effects can be increased when ethopropazine is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when trazodone is combined with clidinium.


The risk or severity of adverse effects can be increased when diflunisal is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when loxapine is combined with HEROIN.


The risk or severity of adverse effects can be increased when dexamethasone is combined with atorvastatin.


The risk or severity of adverse effects can be increased when protriptyline is combined with isoproterenol.


The risk or severity of adverse effects can be increased when clomipramine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when prazepam is combined with ethosuximide.


The risk or severity of adverse effects can be increased when tiapride is combined with efavirenz.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when lisinopril is combined with Nepafenac.


The risk or severity of adverse effects can be increased when trapidil is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when atenolol is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Clobetasone is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when levorphanol is combined with Desloratadine.


The risk or severity of adverse effects can be increased when levorphanol is combined with zaleplon.


The risk or severity of adverse effects can be increased when levorphanol is combined with mepivacaine.


The risk or severity of adverse effects can be increased when lidocaine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when BOPINDOLOL is combined with floctafenine.


The risk or severity of adverse effects can be increased when Voriconazole is combined with venlafaxine.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Deferasirox.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with carbamazepine.


The risk or severity of adverse effects can be increased when oxaprozin is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when quinapril is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with Deferasirox.


The risk or severity of adverse effects can be increased when thiopental is combined with cetirizine.


The risk or severity of adverse effects can be increased when clozapine is combined with Riociguat.


The risk or severity of adverse effects can be increased when Clofarabine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when HEROIN is combined with doxepin.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with leflunomide.


The risk or severity of adverse effects can be increased when Iloperidone is combined with methylphenidate.


The risk or severity of adverse effects can be increased when diazepam is combined with Retigabine.


The risk or severity of adverse effects can be increased when nisoldipine is combined with Riociguat.


The risk or severity of adverse effects can be increased when reserpine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when mecamylamine is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when buspirone is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Clobetasone is combined with mefloquine.


The risk or severity of adverse effects can be increased when quazepam is combined with topiramate.


The risk or severity of adverse effects can be increased when ILOPROST is combined with mesalamine.


The risk or severity of adverse effects can be increased when metoclopramide is combined with perphenazine.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with loteprednol.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when Eletriptan is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when rasagiline is combined with domperidone.


The risk or severity of adverse effects can be increased when cilnidipine is combined with penbutolol.


The risk or severity of adverse effects can be increased when methysergide is combined with buprenorphine.


The risk or severity of adverse effects can be increased when metolazone is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when thiothixene is combined with triflupromazine.


The risk or severity of adverse effects can be increased when DESONIDE is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when DESONIDE is combined with memantine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Normethadone.


The risk or severity of adverse effects can be increased when nimodipine is combined with hydralazine.


The risk or severity of adverse effects can be increased when metoclopramide is combined with pimozide.


The risk or severity of adverse effects can be increased when prazepam is combined with olanzapine.


The risk or severity of adverse effects can be increased when cabergoline is combined with metoclopramide.


The risk or severity of adverse effects can be increased when metoclopramide is combined with sertraline.


The risk or severity of adverse effects can be increased when mirtazapine is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when niflumic acid is combined with alclofenac.


The risk or severity of adverse effects can be increased when zopiclone is combined with sevoflurane.


The risk or severity of adverse effects can be increased when nimodipine is combined with pravastatin.


The risk or severity of adverse effects can be increased when oxycodone is combined with ketamine.


The risk or severity of adverse effects can be increased when sulfamerazine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when pramipexole is combined with benazepril.


The risk or severity of adverse effects can be increased when Etidocaine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when thiopental is combined with Normethadone.


The risk or severity of adverse effects can be increased when Miltefosine is combined with nilvadipine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Flibanserin.


The risk or severity of adverse effects can be increased when protriptyline is combined with vigabatrin.


The risk or severity of adverse effects can be increased when benazepril is combined with Sodium aurothiomalate.


The risk or severity of adverse effects can be increased when rasagiline is combined with sevoflurane.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when methysergide is combined with clarithromycin.


The risk or severity of adverse effects can be increased when rasagiline is combined with metoclopramide.


The risk or severity of adverse effects can be increased when rasagiline is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when sumatriptan is combined with paroxetine.


The risk or severity of adverse effects can be increased when furazolidone is combined with mianserin.


The risk or severity of adverse effects can be increased when DESONIDE is combined with donepezil.


The risk or severity of adverse effects can be increased when clemastine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when ATROPINE is combined with tubocurarine.


The risk or severity of adverse effects can be increased when niflumic acid is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when cocaine is combined with efavirenz.


The risk or severity of adverse effects can be increased when procarbazine is combined with domperidone.


The risk or severity of adverse effects can be increased when desoximetasone is combined with fleroxacin.


The risk or severity of adverse effects can be increased when hydromorphone is combined with pentazocine.


The risk or severity of adverse effects can be increased when niflumic acid is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when Almotriptan is combined with promethazine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with lisinopril.


The risk or severity of adverse effects can be increased when Bortezomib is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Pentolinium is combined with HEROIN.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with atorvastatin.


The risk or severity of adverse effects can be increased when metyrapone is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when isoflurane is combined with phenoxybenzamine.


The risk or severity of adverse effects can be increased when propofol is combined with levorphanol.


The risk or severity of adverse effects can be increased when celecoxib is combined with Tixocortol.


The risk or severity of adverse effects can be increased when enalapril is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when ILOPROST is combined with papaverine.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when ILOPROST is combined with nifedipine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with loratadine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with ramipril.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with alclometasone.


The risk or severity of adverse effects can be increased when cilnidipine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when carprofen is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when Nabilone is combined with trandolapril.


The risk or severity of adverse effects can be increased when lorazepam is combined with dyclonine.


The risk or severity of adverse effects can be increased when lorazepam is combined with pentobarbital.


The risk or severity of adverse effects can be increased when mepivacaine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when carprofen is combined with Deferasirox.


The risk or severity of adverse effects can be increased when amoxapine is combined with meclizine.


The risk or severity of adverse effects can be increased when tetracaine is combined with desipramine.


The risk or severity of adverse effects can be increased when doxycycline is combined with oxycodone.


The risk or severity of adverse effects can be increased when methocarbamol is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Fospropofol is combined with levodopa.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when reserpine is combined with zonisamide.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with dextromethorphan.


The risk or severity of adverse effects can be increased when glutethimide is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Articaine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with methazolamide.


The risk or severity of adverse effects can be increased when clonidine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when clemastine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when carisoprodol is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when oxymorphone is combined with ondansetron.


The risk or severity of adverse effects can be increased when zaleplon is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when oxymorphone is combined with tiagabine.


The risk or severity of adverse effects can be increased when HEROIN is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when zaleplon is combined with flunarizine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when triamterene is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with trimipramine.


The risk or severity of adverse effects can be increased when Linagliptin is combined with fosinopril.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when desipramine is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when Asenapine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Asenapine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when etodolac is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Telithromycin is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Trametinib.


The risk or severity of adverse effects can be increased when tolmetin is combined with DESONIDE.


The risk or severity of adverse effects can be increased when trapidil is combined with diflunisal.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with zotepine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when zotepine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when ramipril is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when loratadine is combined with scopolamine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with etoposide.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with clomipramine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when ramipril is combined with Nebivolol.


The risk or severity of adverse effects can be increased when butorphanol is combined with theobromine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Olopatadine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with moclobemide.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with amoxapine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when sulpiride is combined with etizolam.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Melatonin.


The risk or severity of adverse effects can be increased when promazine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with clonazepam.


The risk or severity of adverse effects can be increased when haloperidol is combined with gabapentin.


The risk or severity of adverse effects can be increased when propofol is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when diclofenac is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when bromocriptine is combined with rivastigmine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with topiramate.


The risk or severity of adverse effects can be increased when propofol is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when tolterodine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Difenoxin is combined with paroxetine.


The risk or severity of adverse effects can be increased when felbamate is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Almotriptan is combined with quetiapine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when nimesulide is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when loxapine is combined with propofol.


The risk or severity of adverse effects can be increased when dipyridamole is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when flunarizine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with triprolidine.


The risk or severity of adverse effects can be increased when flunisolide is combined with memantine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with methocarbamol.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when valsartan is combined with methazolamide.


The risk or severity of adverse effects can be increased when terconazole is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when ethanol is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with clomipramine.


The risk or severity of adverse effects can be increased when ethanol is combined with duloxetine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with valsartan.


The risk or severity of adverse effects can be increased when Normethadone is combined with scopolamine.


The risk or severity of adverse effects can be increased when nicardipine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Normethadone is combined with D-mannitol.


The risk or severity of adverse effects can be increased when sevoflurane is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with nifedipine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with ramipril.


The risk or severity of adverse effects can be increased when sevoflurane is combined with papaverine.


The risk or severity of adverse effects can be increased when reserpine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Normethadone is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when oxycodone is combined with midazolam.


The risk or severity of adverse effects can be increased when Normethadone is combined with flunarizine.


The risk or severity of adverse effects can be increased when meperidine is combined with felbamate.


The risk or severity of adverse effects can be increased when Tapentadol is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when dipyridamole is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when oxymorphone is combined with topiramate.


The risk or severity of adverse effects can be increased when Etidocaine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Etidocaine is combined with zotepine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Icatibant is combined with alclometasone.


The risk or severity of adverse effects can be increased when trimethoprim is combined with methotrexate.


The risk or severity of adverse effects can be increased when fosinopril is combined with labetalol.


The risk or severity of adverse effects can be increased when floctafenine is combined with formestane.


The risk or severity of adverse effects can be increased when floctafenine is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when fosinopril is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when glutethimide is combined with Flibanserin.


The risk or severity of adverse effects can be increased when pergolide is combined with ambroxol.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Droxicam is combined with desoximetasone.


The risk or severity of adverse effects can be increased when chloroquine is combined with alclometasone.


The risk or severity of adverse effects can be increased when Flupentixol is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when procaine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when olanzapine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when Naftifine is combined with dexamethasone.


The risk or severity of adverse effects can be increased when ketoprofen is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when Agomelatine is combined with tizanidine.


The risk or severity of adverse effects can be increased when sotalol is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when sulpiride is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when sevoflurane is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when quinidine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when terconazole is combined with fluvastatin.


The risk or severity of adverse effects can be increased when benzocaine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when flumethasone is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when fenbufen is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when morphine is combined with MOXONIDINE.


The risk or severity of adverse effects can be increased when Asenapine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Conivaptan is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Conivaptan is combined with phentolamine.


The risk or severity of adverse effects can be increased when trapidil is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when Conivaptan is combined with tizanidine.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when Treprostinil is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when propoxyphene is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with malathion.


The risk or severity of adverse effects can be increased when Droxicam is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when tizanidine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when oxycodone is combined with Agomelatine.


The risk or severity of adverse effects can be increased when chloroquine is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Fospropofol.


The risk or severity of adverse effects can be increased when tolnaftate is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when zaleplon is combined with Melatonin.


The risk or severity of adverse effects can be increased when Escitalopram is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when zaleplon is combined with promethazine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with DESONIDE.


The risk or severity of adverse effects can be increased when Pramocaine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with promethazine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with clonazepam.


The risk or severity of adverse effects can be increased when proparacaine is combined with clonidine.


The risk or severity of adverse effects can be increased when butorphanol is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when temazepam is combined with codeine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Melatonin.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with scopolamine.


The risk or severity of adverse effects can be increased when Salsalate is combined with budesonide.


The risk or severity of adverse effects can be increased when spironolactone is combined with lisinopril.


The risk or severity of adverse effects can be increased when spironolactone is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when amitriptyline is combined with citalopram.


The risk or severity of adverse effects can be increased when mecamylamine is combined with methadone.


The risk or severity of adverse effects can be increased when sulindac is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when halothane is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when felodipine is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when lidocaine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with tiapride.


The risk or severity of adverse effects can be increased when pentamidine is combined with nimodipine.


The risk or severity of adverse effects can be increased when fluocinonide is combined with edrophonium.


The risk or severity of adverse effects can be increased when pentobarbital is combined with levodopa.


The risk or severity of adverse effects can be increased when hydromorphone is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when pentobarbital is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when codeine is combined with flurazepam.


The risk or severity of adverse effects can be increased when clonazepam is combined with Iloperidone.


The risk or severity of adverse effects can be increased when PRIMAQUINE is combined with dapsone.


The risk or severity of adverse effects can be increased when codeine is combined with furosemide.


The risk or severity of adverse effects can be increased when Halazepam is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when triazolam is combined with ethosuximide.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Pizotifen.


The risk or severity of adverse effects can be increased when ATROPINE is combined with buprenorphine.


The risk or severity of adverse effects can be increased when triazolam is combined with thiopental.


The risk or severity of adverse effects can be increased when fludiazepam is combined with meclizine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when salicylamide is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when metaraminol is combined with MEPHENTERMINE.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when valsartan is combined with diltiazem.


The risk or severity of adverse effects can be increased when mirtazapine is combined with isoproterenol.


The risk or severity of adverse effects can be increased when quinidine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when butorphanol is combined with clidinium.


The risk or severity of adverse effects can be increased when metolazone is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when perphenazine is combined with pimozide.


The risk or severity of adverse effects can be increased when betaxolol is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when midazolam is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when risperidone is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Levomepromazine.


The risk or severity of adverse effects can be increased when risperidone is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Eplerenone is combined with quetiapine.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with halcinonide.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with difluprednate.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with olanzapine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when pramipexole is combined with fosinopril.


The risk or severity of adverse effects can be increased when oxazepam is combined with doxepin.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when etodolac is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when felbamate is combined with Desloratadine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when betaxolol is combined with Eprosartan.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Lomitapide.


The risk or severity of adverse effects can be increased when estazolam is combined with clozapine.


The risk or severity of adverse effects can be increased when ramipril is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with mepivacaine.


The risk or severity of adverse effects can be increased when indomethacin is combined with epirizole.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with galanthamine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Propacetamol.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Levocetirizine.